SCHEMBL21045376

SCHEMBL21045376

Cc1ccccc1-c1ccc(CCCC(=O)Nc2cccnc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 5/20 0.61
TRPV1 Q8NER1 3/20 0.56
LMNA P02545 3/20 0.55
POLB P06746 1/20 0.55
USP2 O75604 1/20 0.54
HDAC3 O15379 2/20 0.53
HDAC4 P56524 2/20 0.53
HDAC1 Q13547 2/20 0.53
HDAC7 Q8WUI4 2/20 0.53
HDAC2 Q92769 2/20 0.53
HDAC10 Q969S8 2/20 0.53
HDAC11 Q96DB2 2/20 0.53
HDAC8 Q9BY41 2/20 0.53
HDAC6 Q9UBN7 2/20 0.53
HDAC9 Q9UKV0 2/20 0.53
HDAC5 Q9UQL6 2/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
NPC1 O15118 1/20 0.52
CASP3 P42574 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29411485 1.00 NOTUM (0.61) NOTUMTRPV1LMNAPOLBUSP2
SCHEMBL21045262 0.89 NOTUM (0.54) NOTUMTRPV1LMNAPOLBUSP2
SCHEMBL29411547 0.89 NOTUM (0.54) NOTUMTRPV1LMNAPOLBUSP2
SCHEMBL29411590 0.87 LMNA (0.54) NOTUMTRPV1LMNAPOLBUSP2
SCHEMBL29411617 0.87 MEN1 (0.69) NOTUMTRPV1LMNAPOLBUSP2
SCHEMBL21045170 0.87 MEN1 (0.69) NOTUMTRPV1LMNAPOLBUSP2
SCHEMBL21045152 0.87 LMNA (0.54) NOTUMTRPV1LMNAPOLBUSP2
SCHEMBL21045372 0.86 LMNA (0.64) NOTUMTRPV1LMNAPOLBUSP2
SCHEMBL21045546 0.84 NOTUM (0.53) NOTUMTRPV1LMNAPOLBUSP2
SCHEMBL29411587 0.84 NOTUM (0.53) NOTUMTRPV1LMNAPOLBUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed
US-11040945-B2 Tubulin inhibitors LIN BIOSCIENCE PTY LTD. 2021-06-22 US disclosed
US-11040945-B2 Tubulin inhibitors LIN BIOSCIENCE PTY LTD. 2021-06-22 US disclosed
WO-2019113242-A1 TUBULIN INHIBITORS Lin BioScience, LLC (US) 2019-06-13 WO disclosed
US-20190169127-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2019-06-06 US disclosed
US-20190169127-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB NOTUM 2328/4885TRPV1 4663/4885LMNA 2547/4885
US-11040945-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB NOTUM 2328/4885TRPV1 4663/4885LMNA 2547/4885
US-20190169127-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB NOTUM 2328/4885TRPV1 4663/4885LMNA 2547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.